UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme

Cancer Research

Volumn 63, Issue 14, 2003, Pages 4167-4173

  Okamoto, Yoshiaki ^a,b   Ozaki, Toshinori ^a   Miyazaki, Kou ^a   Aoyama, Mineyoshi ^a   Miyazaki, Masaru ^b   Nakagawara, Akira ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BROXURIDINE; LIGASE; PROTEASOME; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN 3T3; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE COURSE; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE E2; ONCOGENE UBCH10; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; STOMACH CANCER; TUMOR CELL; UTERUS CANCER;

3T3 CELLS; ANIMALS; CELL DIVISION; GENE EXPRESSION; HUMANS; LIGASES; MICE; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; UBIQUITIN-CONJUGATING ENZYMES;

EID: 0042674162     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hershko, A., and Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem., 67: 425-479, 1998.
2. Joazeiro, C. A. P., and Weissman, A. M. Ring finger proteins: mediators of ubiquitin ligase activity. Cell. 102: 549-552, 2000.
3. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. MDM2 promotes the rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.
4. Kubbutat, M. H. G., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by Mdm2. Nature (Lond.), 387: 299-303, 1997.
5. Honda, R., Tanaka, H., and Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett., 420: 25-27, 1997.
6. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., and Gu, W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature (Lond.), 416: 648-653, 2002.
7. Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M., Ouchi, Y., and Inoue, S. Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth. Nature (Lond.), 417: 871-875, 2002.
8. Irniger, S., Piatti, S., Michaelis, C., and Nasmyth, K. Genes involved in sister chromatid separation are needed for B-type cyclin proteolysis in budding yeast. Cell, 81: 269-277, 1995.
9. King, R. W., Peters, J. M., Tugendreich, S., Rolfe, M., Hieter, P., and Kirschner, M. W. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell, 81: 279-288, 1995.
10. Sudakin, V., Ganoth, D., Dahan. A., Heller, H., Hershko, J., Luca, F. C., Ruderman, J. V., and Hershko, A. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol. Biol. Cell, 6, 185-198, 1995.
11. Tugendreich, S., Tomkiel, J., Earnshaw, W., and Hieter, P. The CDC27HS protein co-localizes with the CDC16HS protein to the centrosome and mitotic spindle and is essential for the metaphase to anaphase transition. Cell, 81: 261-268, 1995.
12. Ciechanover, A. The ubiquitin-proteasome proteolytic pathway. Cell. 79: 13-21, 1994.
13. Lin, Y., Hwang, W. C., and Basavappa, R. Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10. J. Biol. Chem., 277: 21913-21921, 2002.
14. Aristarkhov, A., Eytan, E., Moghe, A., Hershko, A., and Ruderman, J. V. E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins. Proc. Natl. Acad. Sci. USA, 93: 4294-4299, 1996.
15. Yu, H., King, R. W., Peters, J-M., and Kirschner, M. W. Identification of a novel ubiquitin-conjugating enzyme involved in mitotic cyclin degradation. Curr. Biol., 6: 455-466, 1996.
16. Townsley, F. M., Aristarkhov, A., Beck, S., Hershko, A., and Ruderman, J. V. Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc. Natl. Acad. Sci. USA, 94: 2362-2367, 1997.
17. Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Wash. DC), 269: 682-685, 1995.
18. Arvand, A., Bastians, H., Welford, S. M., Thompson, A. D., Ruderman, J. V., and Denny, C. T. EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene, 17: 2039-2045, 1998.
19. McDoniels-Silvers, A. L., Nimri, C. F., Stoner, G. D., Lubet, R. A., and You, M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin. Cancer Res., 8: 1127-1138, 2002.
20. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
21. Shekhar, M. P. V., Lyakhovich, A., Visscher, D. W., Heng, H., and Kondrat, N. Rad6 overexpression induces multinucleation, centrosome amplification, abnormal mitosis, aneuploidy, and transformation. Cancer Res., 62: 2115-2124, 2002.
22. 1. Mol. Cell, 2: 163-171, 1998.
23. Kramer, E. R., Gieffers, C., Holzl, G., Hengstschlager, M., and Peters, J-M. Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family. Curr. Biol., 8: 1207-1210, 1998.
24. Yamanaka, A., Hatakeyama, S., Kominami, K., Kitagawa, M., Matsumoto, M., and Nakayama, K. Cell cycle-dependent expression of mammalian E2-C regulated by the anaphase-promoting complex/cyclosome. Mol. Biol. Cell, 11: 2821-2831, 2000.
25. May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., and Denny, C. T. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FL11 for transformation. Proc. Natl. Acad. Sci. USA, 90: 5752-5756, 1993.
26. May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., and Denny, C. T. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol., 13: 7393-7398, 1993.
27. Lessnick, S. L., Braun, B. S., Denny, C. T., and May, W. A. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene, 10: 423-431, 1995.
28. May, W. A., Arvand, A., Thompson, A. D., Braun, B. S., Wright, M., and Denny, C. T. EWS/FLI1-induced manic fringe renders NIH3T3 cells tumorigenic. Nat. Genet., 17: 495-497, 1997.
29. Blumenfeld, N., Gonen, H., Mayer, A., Smith, C. E., Siegel, N. R., Schwartz, A. L., and Ciechanover, A. Purification and characterization of a novel species of ubiquitin-carrier protein, E2, that is involved in degradation of non-"N-end rule" protein substrates. J. Biol. Chem., 269: 9574-9581, 1994.
30. Ciechanover, A., Shkedy, D., Oren, M., and Bercovich, B. Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein. E2. J. Biol. Chem., 269: 9582-9589, 1994.
31. Nuber, U., Schwarz, S., Kaiser, P., Schneider, R., and Scheffner, M. Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterization of their interaction with E6-AP and RSP5. J. Biol. Chem., 271: 2795-2800, 1996.